Back to article: The impact of endothelial cell death in the brain and its role after stroke: A systematic review

TABLE 2. Distribution of records according to cell death mechanisms and markers.

7-ADD: 7-aminoactinomycin D; BAD: BCL2 associated agonist of cell death; BAK: BCL2 antagonist/killer 1; BAX: BCL2 associated X, apop-tosis regulator; BCL2: apoptosis regulator family; BCL-XL: BCL2 like 1 (BCL2L1); BID: BH3 interacting domain death agonist; BIM: BCL2-interacting mediator of cell death (also BCL2 like 11, BCL2L11); BNIP3: BCL2 interacting protein 3; CCK-8: Cell Counting Kit-8; DRP1: dy-namin-related protein 1; EM: electron microscopy; ISL: in situ ligation; LC3: microtubule-associated protein 1A/1B-light chain 3; MTT: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; phospho-p38: phosphorylated p38 mitogen-activated protein kinase; phos-pho-JNK: phosphorylated c-Jun N-terminal kinase; RIP: receptor-interacting serine/threonine-protein kinase; TUNEL: TdT-mediated dUTP-biotin nick end labeling; WST: water-soluble tetrazolium.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. Please refer to our "privacy statement" and our "terms of use" for further information.